RGC Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

33.980

Open

29.220

VWAP

32.00

Vol

558.00K

Mkt Cap

16.00B

Low

28.760

Amount

18.00M

EV/EBITDA(TTM)

--

Total Shares

494.00M

EV

14.00B

EV/OCF(TTM)

--

P/S(TTM)

--

Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.

Show More

Events Timeline

(ET)

2026-01-27

10:10:00

Regencell Bioscience Stock Rises 15.4% to $33.69

2026-01-26 (ET)

2026-01-26

10:10:00

Regencell Bioscience Shares Down 10.9% to $28.00

2026-01-23 (ET)

2026-01-23

10:10:00

Regencell Bioscience Stock Rises 15% to $35.40

2026-01-22 (ET)

2026-01-22

12:10:00

Regencell Bioscience Shares Rise 32.5% to $29.03

2026-01-22

10:10:00

Regencell Bioscience Shares Rise 35.9% to $29.78

2026-01-21 (ET)

2026-01-21

10:10:00

Regencell Bioscience Shares Down 6.8% to $22.67

2026-01-20 (ET)

2026-01-20

12:10:00

Regencell Bioscience Shares Down 8.8% to $25.01

2026-01-20

10:10:00

Regencell Bioscience Shares Down 9.0% to $24.97

2026-01-16 (ET)

2026-01-16

10:10:00

Regencell Bioscience Shares Down 9.6% to $27.16

News

an image of Benzinga

HCA Healthcare Surges After Strong Q4 Earnings and Upgraded FY25 Guidance

an image of Barron's

S&P 500 Futures Decline in Pre-Market Trading; Intel and Installed Building Products Underperform

an image of Benzinga

Ericsson (ERIC) Reports Q4 Earnings Beat, Shares Surge 7.1%

an image of Barron's

U.S. Markets Gained Ground on Thursday, with Regencell Bioscience Driving the Upward Trend

an image of Benzinga

Eagle Bancorp Reports Q4 Earnings Beat, Shares Surge 19.8%

an image of Barron's

U.S. Markets Gained Ground on Wednesday, with Moderna Driving the Surge

Valuation Metrics

The current forward P/E ratio for Regencell Bioscience Holdings Ltd (RGC.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Regencell Bioscience Holdings Ltd 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

an image of dotted line Image

N/A

5Y Average PE

0.00

Current PE

0.00

Overvalued PE

0.00

Undervalued PE

0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

an image of dotted line Image

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

an image of dotted line Image

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

entonces que acciones?

Intellectia · 74 candidates

Market Cap: >= 3.00BRsi Category: moderateWeek Price Change Pct: $5.00 - $20.00Ema 20: >= -100Ema 60: >= -100Monthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

Sasol Ltd

5.00B

Lemonade Inc

7.00B

Telecom Argentina SA

6.00B

Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP

19.00B

Korea Electric Power Corp

28.00B

Posco Holdings Inc

19.00B

Intellectia · 2866 candidates

Pe Ttm: <= 10

Ticker

Name

Market Cap$

SL Green Realty Corp

3.00B

Avadel Pharmaceuticals PLC

2.00B

HubSpot Inc

16.00B

Arrowhead Pharmaceuticals Inc

9.00B

PDF Solutions Inc

1.00B

Trivago NV

198.00M

what stocks is up more than 500%

Intellectia · 22 candidates

Weekly Average Turnover: >= 1,000,000Year Price Change Pct: >= $500.00

Ticker

Name

Market Cap$

Sandisk Corp

73.00B

Regencell Bioscience Holdings Ltd

11.00B

Abivax SA

9.00B

Celcuity Inc

5.00B

Terns Pharmaceuticals Inc

4.00B

Hycroft Mining Holding Corporation

3.00B

Whales Holding RGC

Trading Trends

People Also Watch

Frequently Asked Questions

What is Regencell Bioscience Holdings Ltd (RGC) stock price today?

The current price of RGC is 32.05 USD — it has increased 9.76 % in the last trading day.

What is Regencell Bioscience Holdings Ltd (RGC)'s business?

Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.

What is the price predicton of RGC Stock?

Wall Street analysts forecast RGC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for RGC is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Regencell Bioscience Holdings Ltd (RGC)'s revenue for the last quarter?

Regencell Bioscience Holdings Ltd revenue for the last quarter amounts to NaN USD, decreased % YoY.

What is Regencell Bioscience Holdings Ltd (RGC)'s earnings per share (EPS) for the last quarter?

Regencell Bioscience Holdings Ltd. EPS for the last quarter amounts to USD, decreased % YoY.

How many employees does Regencell Bioscience Holdings Ltd (RGC). have?

Regencell Bioscience Holdings Ltd (RGC) has 12 emplpoyees as of January 28 2026.

What is Regencell Bioscience Holdings Ltd (RGC) market cap?

Today RGC has the market capitalization of 16.00B USD.